Meda AB

Type: Company
Name: Meda AB
Nationality: Sweden
Web Address: http://www.meda.se/
Fact Sheet: Fact Sheet for Meda AB
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

SADIF Analytics releases new summary due diligence report for Meda AB (MEDA A)

- SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Meda AB (MEDA A) and produced a report, rating the company's attractiveness to long-term investors.Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due ... [Published PR inside - Sep 25 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Sun pharma to raise Rs 120 bn through QIP

Construction Update : Deals| 15 Sep 2014 India’s largest drug maker by value, Sun Pharmaceutical has plan to raise Rs 120 bn through qualified institutional placement (QIP) and is seeking shareholders nod for the same. It also plans to raise Rs 500 bn ... [Published ASAPP - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Sun Pharma rises on plan to raise QIP worth Rs 12,000 crore

Sun Pharmaceutical Industries is currently trading at Rs. 809.00, up by 3.10 points or 0.38% from its previous closing of Rs. 805.90 on the BSE.The scrip opened at Rs. 804.85 and has touched a high and low of Rs. 815.00 and Rs. 804.85 respectively. So ... [Published Arihant Capital - Sep 15 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 3 reports

Sun Pharma To Raise Funds Through QIP

India’s largest pharma company by value, @Sun_Pharmaceutical is planning to raise INR 120 Bn through QIP and is seeking shareholders nod for the same.It also planning to raise INR 500 Bn in debt. The end use of huge amount raised is not known, however ... [Published Deal Curry - Sep 12 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Meda divests manufacturing unit in Lakewood, New Jersey

Meda AB (STO: MEDAA), a specialty pharmaceutical company, announced on Thursday the signing of an agreement to divest the manufacturing unit in Lakewood, New Jersey, to the contract manufacturer DPT. Financial details of this divestment were not avai ... [Published Individual.com - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

17D Rhinitis/rhinorrhea (Intranasal Products)

ASTELIN Meda RxAntihistamine. Azelastine HCI 137mcg/ spray; aqueous nasal spray; contains benzalkonium chloride.Indications: Seasonal allergic rhinitis. Vasomotor rhinitis.Adults: 2 sprays in each nostril twice daily.Children: Seasonal allergic rhini ... [Published HighBeam Research - Sep 03 2014]
First reported May 07 2014 - Updated May 08 2014 - 1 reports

Meda AB (publ) AGM bulletin

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: At the annual general meeting (AGM) on May 7, 2014, of Meda AB (STO:MEDAA) (publ), corporate ID 556427-2812, Box 906, SE-170 09 Solna, Sweden, declared a dividend of 2,50 SEK per share. The AGM adopted ... [Published Business Wire Health News - May 07 2014]
First reported May 07 2014 - Updated May 07 2014 - 1 reports

MEDA: Interim Report, January-March 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDAA): January-March 2014·The Group’s net sales reached SEK 3,365 million (3,199), corresponding to organic growth[1] of 3% compared to the previous year.·EBITDA was SEK 1,010 million (923), ... [Published Business Wire Health News - May 07 2014]
First reported Apr 28 2014 - Updated Apr 28 2014 - 1 reports

Statement by the Board of Directors of Meda in relation to Mylan, Inc.

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: This statement is made by the Board of Directors (the ”Board”) of Meda AB (publ) (”Meda”) (STO:MEDAA) pursuant to the Securities Markets Act and//or the Financial Instruments Trading Act. The Board hereby ... [Published Business Wire Health News - Apr 28 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

Meda and Valeant Terminates Joint Ventures

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) has reached an agreement with Valeant to terminate the companies’ joint ventures in Canada, Mexico and Australia in the second quarter of 2014. In all three countries own Meda affiliates ... [Published Business Wire Health News - Apr 07 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Swedish drugmaker Meda spurns Mylan takeover approach

By Mia Shanley STOCKHOLM (Reuters) - Sweden's Meda AB said on Friday it had rejected a takeover approach by U.S. generic drugmaker Mylan Inc, scuppering a potential deal to create a combined company worth around $24 billion. Meda said it had... ... [Published Yahoo! Health News - Apr 04 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Statement by the Board of Directors of Meda

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: This statement is made by the Board of Directors (the ”Board”) of Meda AB (publ) (”Meda”)(STO:MEDAA) pursuant to the Securities Markets Act and/or the Financial Instruments Trading act. The Board hereby ... [Published Business Wire Health News - Apr 04 2014]

Quotes

Report stated that company wanted shareholders approval to "issue, offer and allot equity shares or non-convertible securities, other than warrants."
Sun Pharma stated the company wanted shareholders’ approval to "issue, offer and allot equity shares or non-convertible securities, other than warrants, up to an amount of Rs 12,000 crore ($2 billion), to qualified institutional buyers pursuant to a QIP." It is also considering shareholders' nod for borrowing Rs 50,000 crore
"Tax is clearly a benefit but it's not the primary rationale," he added. "My own point of view is the debate would be more appropriately shifted to tax reform. Companies like ours need access to our global cash flows and today we are at a disadvantage compared to our competitors."
...harmacal's commitment to women's health has never been stronger," says Dan Kibbe, senior vice president, Pharmaceutical Division, Mission Pharmacal. "The addition of Elestrin further enhances our position as one of the most valuable partners in providing healthcare solutions for obstetricians and gynaecologists (OB/GYNs) and their patients in the women's healthcare community."

More Content

All (34) | News (17) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (2) | Press Releases (6)
sort by: Date | Relevance
SADIF Analytics releases new summary due dilige... [Published PR inside - Sep 25 2014]
Sun pharma to raise Rs 120 bn through QIP [Published ASAPP - Sep 15 2014]
Sun Pharma rises on plan to raise QIP worth Rs ... [Published Arihant Capital - Sep 15 2014]
Sun Pharma To Raise Funds Through QIP [Published Deal Curry - Sep 12 2014]
Sun Pharma plans to raise QIP worth Rs 12,000 c... [Published Indian-Commodity - Sep 12 2014]
Sun Pharma seeks shareholders nod for QIP [Published India Infoline - Sep 12 2014]
Sun Pharma seeks shareholders' nod for Rs 12,00... [Published Business Standard India - Sep 11 2014]
Meda divests manufacturing unit in Lakewood, Ne... [Published Individual.com - Sep 05 2014]
17D Rhinitis/rhinorrhea (Intranasal Products) [Published HighBeam Research - Sep 03 2014]
Shire Agrees to AbbVie $55B Takeover Offer [Published The Street Latest - Jul 18 2014]
Mission Pharmacal starts promotion of Elestrin ... [Published PharmaBiz - May 31 2014]
Mission Pharmacal Begins Exclusive Promotion of... [Published PR Newswire: General Business - May 29 2014]
Listing of bond loan(s) issued by Meda AB (publ... [Published GlobeNewswire: Acquisitions News - May 21 2014]
Meda AB (publ) AGM bulletin [Published Business Wire Health News - May 07 2014]
Meda AB (publ) AGM bulletin [Published GlobeNewswire: Advertising News - May 07 2014]
MEDA: Interim Report, January-March 2014 [Published Business Wire Health News - May 07 2014]
Tax Relief – Country: SwedenSecurity: Meda AB C... [Published DTCC - May 07 2014]
ASTEPRO (Azelastine Hydrochloride) Spray, Meter... [Published DailyMed Drug Label Updates for the last seven ... - May 01 2014]
Statement by the Board of Directors of Meda in ... [Published Business Wire Health News - Apr 28 2014]
Statement by the Board of Directors of Meda in ... [Published GlobeNewswire: Acquisitions News - Apr 28 2014]
Alstom, Glaxo lead EU stocks in second straight... [Published Taipei Times Online - Apr 26 2014]
Meda and Valeant terminates joint ventures [Published GlobeNewswire: Advertising News - Apr 07 2014]
Meda and Valeant Terminates Joint Ventures [Published Business Wire Health News - Apr 07 2014]
Swedish firm rejects Mylan transaction bid [Published Observer-Reporter - Apr 05 2014]
Worst Session in Months for Tech; Dow Logs Trip... [Published Schaeffers Research - Apr 04 2014]
Will This Upgrade Help Mylan (MYL) Stock Today? [Published The Street Latest - Apr 04 2014]
Swedish drugmaker Meda spurns Mylan takeover ap... [Published Yahoo! Health News - Apr 04 2014]
Statement by the Board of Directors of Meda [Published GlobeNewswire: Acquisitions News - Apr 04 2014]
Statement by the Board of Directors of Meda [Published Business Wire Health News - Apr 04 2014]
Trading halt in Corporate Bonds issued by Meda ... [Published GlobeNewswire: Advertising News - Apr 04 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Mission Pharmacal Begins Exclusive Promotion of... [Published PR Newswire: General Business - May 29 2014]
SAN ANTONIO, May 29, 2014 /PRNewswire/ -- Mission Pharmacal Company has begun exclusive promotion of Elestrin® (estradiol gel) 0.06% in the United States through an agreement with Meda AB. Elestrin is a prescription medicine approved by the Food and ...
Meda AB (publ) AGM bulletin [Published Business Wire Health News - May 07 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: At the annual general meeting (AGM) on May 7, 2014, of Meda AB (STO:MEDAA) (publ), corporate ID 556427-2812, Box 906, SE-170 09 Solna, Sweden, declared a dividend of 2,50 SEK per share. The AGM adopted ...
MEDA: Interim Report, January-March 2014 [Published Business Wire Health News - May 07 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDAA): January-March 2014·The Group’s net sales reached SEK 3,365 million (3,199), corresponding to organic growth[1] of 3% compared to the previous year.·EBITDA was SEK 1,010 million (923), ...
ASTEPRO (Azelastine Hydrochloride) Spray, Meter... [Published DailyMed Drug Label Updates for the last seven ... - May 01 2014]
Updated Date: Apr 28, 2014 EST ...
Statement by the Board of Directors of Meda in ... [Published Business Wire Health News - Apr 28 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: This statement is made by the Board of Directors (the ”Board”) of Meda AB (publ) (”Meda”) (STO:MEDAA) pursuant to the Securities Markets Act and//or the Financial Instruments Trading Act. The Board hereby ...
1 2

Press Releases

sort by: Date | Relevance
Listing of bond loan(s) issued by Meda AB (publ... [Published GlobeNewswire: Acquisitions News - May 21 2014]
Meda AB (publ) AGM bulletin [Published GlobeNewswire: Advertising News - May 07 2014]
Statement by the Board of Directors of Meda in ... [Published GlobeNewswire: Acquisitions News - Apr 28 2014]
Meda and Valeant terminates joint ventures [Published GlobeNewswire: Advertising News - Apr 07 2014]
Statement by the Board of Directors of Meda [Published GlobeNewswire: Acquisitions News - Apr 04 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.